Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.31 is 53% below its 5-year average of 4.86, near the low end of its 5-year range (0.00–12.07).
As of the fiscal period ended Tuesday, June 30, 2026. 41.80% above its 12-month average of 1.63.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.31.
QUICK RATIO (ACID-TEST)
2.31
QUICK RATIO (ACID-TEST) AVG TTM
1.63
QUICK RATIO (ACID-TEST) AVG 3Y
3.54
QUICK RATIO (ACID-TEST) AVG 5Y
4.86
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+41.80%
CURRENT VS 3Y AVG
-34.93%
CURRENT VS 5Y AVG
-52.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-31.18%
vs the sector median at left
Market Cap
$143.60M
Quick Ratio (Acid-Test)
10.97
TTM Avg
15.14
3Y Avg
14.07
5Y Avg
22.68
Market Cap
$143.84M
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
Market Cap
$146.27M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$146.28M
Quick Ratio (Acid-Test)
2.99
TTM Avg
3.92
3Y Avg
3.42
5Y Avg
4.30
Market Cap
$139.84M
Quick Ratio (Acid-Test)
3.32
TTM Avg
2.30
3Y Avg
3.60
5Y Avg
5.41
Market Cap
$146.62M
Quick Ratio (Acid-Test)
2.47
TTM Avg
5.26
3Y Avg
13.15
5Y Avg
16.36
Market Cap
$139.47M
Quick Ratio (Acid-Test)
8.04
TTM Avg
11.45
3Y Avg
6.05
5Y Avg
5.52
Market Cap
$139.04M
Quick Ratio (Acid-Test)
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nyxoah S.A. (NYXH) | $143.10M | 2.31 | 1.63 | 3.54 | 4.86 |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 10.97 | 15.14 | 14.07 | 22.68 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 1.23 | 1.14 | 1.35 | 4.96 |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | 3.83 | 1.68 | 1.58 | 2.46 |
| Codexis, Inc. (CDXS)vs › | $146.28M | 2.99 | 3.92 | 3.42 | 4.30 |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | 3.32 | 2.30 | 3.60 | 5.41 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 2.47 | 5.26 | 13.15 | 16.36 |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | 8.04 | 11.45 | 6.05 | 5.52 |
| Immuneering Corporation (IMRX)vs › | $139.04M | 19.47 | 11.39 | 11.91 | 15.23 |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 15.62 | 10.23 | 11.93 | 11.24 |
Quick Ratio
2.31
Excludes inventory
Current Ratio
2.38
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.31 |
| 2026-03-31 | 0.88 |
| 2025-12-31 | 1.16 |
| 2025-09-30 | 1.41 |
| 2025-06-30 | 2.38 |
| 2025-03-31 | 3.35 |
| 2024-12-31 | 4.34 |
| 2024-09-30 | 4.95 |
| 2024-06-30 | 5.16 |
| 2024-03-31 | 3.70 |
| 2023-12-31 | 4.50 |
| 2023-09-30 | 5.84 |
| 2023-06-30 | 6.09 |
| 2023-03-31 | 7.07 |
| 2022-12-31 | 6.72 |
| 2022-09-30 | 5.94 |
| 2022-06-30 | 7.21 |
| 2022-03-31 | 10.38 |
| 2021-12-31 | 12.07 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 6.67 |
| 2021-03-31 | 10.35 |
| 2020-12-31 | 14.69 |
| 2020-09-30 | 14.69 |
| 2020-06-30 | 5.85 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.82 |
| 2019-09-30 | 1.82 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
